This is the authors' abstract. We don't add key points for this paper.
We describe a class of bioconjugation reactions that enables site-specific modification of proteins through enzymatic generation of o-quinone from either tyrosine residues or phenol reagents. The enzymatically generated o-quinone rapidly reacts chemically with numerous common nucleophiles and dienophiles, including thiols, anilines, alkoxyamines, cyclooctynes, and cyclooctenes. Nucleophilic chemoenzymatic reaction with engineered tyrosine residues creates a hydroxytyrosine (HOT) bridge; a similar reaction with phenols creates a hydroxyphenol (HOP). Diels-alder cycloaddition following o-quinone generation results in an arylbicyclodiketone (ABCD). The stability of each conjugate against physiological pH and temperature varies from less than one day to multiple months in vitro.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Holder et al. (2020) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: